CIK 0001671858
- Non-accelerated filer
- Smaller reporting company
ARS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SPRY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811489190
- Phone
- +1 858-771-9307
- Business address
- 11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Silverback Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-01 | Hawkinson Russ Sr. Vice President of Finance | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2022-02-01 | Hawkinson Russ Sr. Vice President of Finance | Grant or award · Stock Option (right to buy) | +28,500 | 28,500 | ||
| 2022-02-01 | Piazza Jonathan Chief Financial Officer | Grant or award | +11,250 | 25,534 | ||
| 2022-02-01 | Piazza Jonathan Chief Financial Officer | Grant or award · Stock Option (right to buy) | +67,500 | 67,500 | ||
| 2022-02-01 | Piazza Jonathan Chief Financial Officer | Grant or award · Stock Option (right to buy) | +42,750 | 42,750 | ||
| 2022-02-01 | Hunder Naomi Chief Medical Officer | Grant or award | +11,250 | 11,250 | ||
| 2022-02-01 | Hunder Naomi Chief Medical Officer | Grant or award · Stock Option (right to buy) | +67,500 | 67,500 | ||
| 2022-02-01 | Hunder Naomi Chief Medical Officer | Grant or award · Stock Option (right to buy) | +42,750 | 42,750 | ||
| 2022-02-01 | Shawver Laura Chief Executive Officer | Grant or award | +27,500 | 107,395 | ||
| 2022-02-01 | Shawver Laura Chief Executive Officer | Grant or award · Stock Option (right to buy) | +165,000 | 165,000 | ||
| 2022-02-01 | Shawver Laura Chief Executive Officer | Grant or award · Stock Option (right to buy) | +104,500 | 104,500 | ||
| 2022-02-01 | Odegard Valerie President and CSO | Grant or award | +16,406 | 16,406 | ||
| 2022-02-01 | Odegard Valerie President and CSO | Grant or award · Stock Option (right to buy) | +98,438 | 98,438 | ||
| 2022-02-01 | Odegard Valerie President and CSO | Grant or award · Stock Option (right to buy) | +49,875 | 49,875 | ||
| 2021-12-13 | ROOT JONATHAN D Director | Other disposition | −2,069,167 | 0 | ||
| 2021-12-13 | ROOT JONATHAN D Director | Other disposition | −105,012 | 0 | ||
| 2021-11-15 | ROOT JONATHAN D Director | Purchase | +2,014 | $8.85 | $18K | 2,364 |
| 2021-06-04 | Thompson Peter A. Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-06-04 | ROOT JONATHAN D Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-06-04 | Powell Andrew Kenneth William Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 |
Page 27 of 31 · 602 trades